Beijing has not achieved all of its “Made in China 2025” (MIC2025) goals – particularly in aviation and integrated circuits…
Read More »biopharma
Hong Kong-based venture capital firm ORI Capital plans to launch a new fund to invest in Chinese healthcare start-ups, as…
Read More »